Search research articles
Contact Us
Filters
Showing results (1-10 of 142) with videos related to
Page
of 15
Sort By:
Trends in Immunology
|
January 24, 2024
Mononuclear myeloid cells can shape neutrophils in brain tumors
Sven Brandau
European Urology
|
January 29, 2008
Editorial comment on: celecoxib has potent antitumour effects as a single agent and in combination with BCG immunotherapy in a model of urothelial cell carcinoma
Sven Brandau
The Journal of Urology
|
February 24, 2009
Tumor associated macrophages: predicting bacillus Calmette-Guerin immunotherapy outcomes
Sven Brandau
Cancer Immunology, Immunotherapy : CII
|
March 20, 2019
MDSC and beyond: a symposium-in-writing on myeloid cells with immunoregulatory activity by members of the Mye-EUNITER network
Sven Brandau
The Journal of Urology
|
December 13, 2006
Local and systemic immune suppression in bladder cancer
Sven Brandau
Seminars in Cancer Biology
|
March 5, 2013
The dichotomy of neutrophil granulocytes in cancer
Sven Brandau
The Journal of Urology
|
August 13, 2003
Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer
Andreas Böhle, Sven Brandau
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
July 3, 2007
Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement
Sven Brandau, Henrik Suttmann
The Journal of Urology
|
June 7, 2002
Re: Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain shirota on the murine orthotopic bladder tumor MBT-2
Sven Brandau, Andreas Böhle
Cancer Biology & Therapy
|
December 25, 2008
CD40L gene transfer in immunotherapy of cancer: more than co-stimulation?
Christoph Bergmann, Sven Brandau
Page
of 15
Search research articles
Search
Showing results (1-10 of 142) with videos related to
Sort By:
Page
of 15
Trends in Immunology
|
January 24, 2024
Mononuclear myeloid cells can shape neutrophils in brain tumors
Sven Brandau
European Urology
|
January 29, 2008
Editorial comment on: celecoxib has potent antitumour effects as a single agent and in combination with BCG immunotherapy in a model of urothelial cell carcinoma
Sven Brandau
The Journal of Urology
|
February 24, 2009
Tumor associated macrophages: predicting bacillus Calmette-Guerin immunotherapy outcomes
Sven Brandau
Cancer Immunology, Immunotherapy : CII
|
March 20, 2019
MDSC and beyond: a symposium-in-writing on myeloid cells with immunoregulatory activity by members of the Mye-EUNITER network
Sven Brandau
The Journal of Urology
|
December 13, 2006
Local and systemic immune suppression in bladder cancer
Sven Brandau
Seminars in Cancer Biology
|
March 5, 2013
The dichotomy of neutrophil granulocytes in cancer
Sven Brandau
The Journal of Urology
|
August 13, 2003
Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer
Andreas Böhle, Sven Brandau
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
July 3, 2007
Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement
Sven Brandau, Henrik Suttmann
The Journal of Urology
|
June 7, 2002
Re: Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain shirota on the murine orthotopic bladder tumor MBT-2
Sven Brandau, Andreas Böhle
Cancer Biology & Therapy
|
December 25, 2008
CD40L gene transfer in immunotherapy of cancer: more than co-stimulation?
Christoph Bergmann, Sven Brandau
Page
of 15